$1.29
+0.02 (+1.57%)
Open$1.32
Previous Close$1.27
Day High$1.32
Day Low$1.25
52W High$5.53
52W Low$1.15
Volume—
Avg Volume246.8K
Market Cap6.90M
P/E Ratio—
EPS$-1.89
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,282.9% upside
Current
$1.29
$1.29
Target
$43.64
$43.64
$27.68
$43.64 avg
$53.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.54M | 2.73M | 1.47M |
| Net Income | -10,182,893 | -7,070,907 | 533.2K |
| Profit Margin | -287.4% | -273.0% | 36.3% |
| EBITDA | -10,199,094 | -7,475,610 | 838.1K |
| Free Cash Flow | — | — | 521.2K |
| Rev Growth | +29.6% | +29.6% | +11.3% |
| Debt/Equity | 0.02 | 0.02 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |